10 results
COVID-19 Signs and Symptoms at the time of Presentation

Fever
Myalgia
Headache
Rinorrhea
Sore Throat
Dyspnea
Chest Tightness
Cough
Sputum
Hemoptysis
Nausea/Vomiting
Diarrhea

Dr. Josh Farkas @pulmcrit via Internet
COVID-19 Signs and ... Symptoms at the ... Fever Myalgia ... Throat Dyspnea Chest ... #SARSCoV2 #EBM
COVID-19 on POCUS

I'm infected COVID19.  Lung POCUS  day 4 after onset of symptoms. No
COVID-19 on POCUS ... I'm infected COVID19 ... after onset of symptoms ... No fever, basal ... #Ultrasound #SARSCoV2
â–º
COVID-19 on POCUS

I am infected with COVID-19. This is my own #POCUS 2 days after the
after the onset of symptoms ... No fever and basal ... observed in the chest ... POCUS #Clinical #Lung ... #Ultrasound #SARSCoV2
â–º
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
2020 Clinical Presentation ... • Fever: hospitalized ... 30%; can be only symptom ... occur before other symptoms ... Algorithm #Protocol #SARSCoV2
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Presentation: ... • 80% have fever ... decubitus - air fluid level ... Intervention: - Fevers ... shows a small, stable
Sarcoidosis - Diagnosis and Management Summary
Epidemiology
1) High incidence in Scandinavian countries (11-24 cases per 100,000 individuals
granulomas within the lungs ... General: fever, ... dyspnea, cough, chest ... syndrome: ACUTE, fever ... with fever, parotitis
Nontuberculous Mycobacteria (NTM) Infections 

Mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and
inhibitors • Presentation ... : Fever, night sweats ... Manifestations: • Fever ... • Fever and weight ... • Clinical (Symptoms
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
fatty tissue Presentation ... gradually with symptoms ... Fever 4. ... Improvement in symptoms ... of most common presentation
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
or family - Ever ... Stable patients ... one post op Cardiology ... change CV risk Chest ... unless prior heart/lung
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
hallucinations, rashes/long-term ... hypokalemia, phlebitis, fever ... chills, dyspnea, chest ... #antifungals #comparison ... #table #pharmacology